EFFECTS OF OCT2 AND MATE1 POLYMORPHISMS AND INHIBITION BY TRIMETHOPRIM ON METFORMIN PHARMACOKINETICS.

被引：0
|
作者：
Czock, D. [1 ]
Grun, B. [1 ]
Kiessling, M. [1 ]
Burhenne, J. [1 ]
Riedel, K. [1 ]
Weiss, J. [1 ]
Rauch, G. [2 ]
Haefeli, W. E. [1 ]
机构：
[1] Univ Heidelberg Hosp, Heidelberg, Germany
[2] Univ Heidelberg, Heidelberg, Germany
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S63 / S64
页数：2
相关论文
共 50 条
  • [1] GENETIC POLYMORPHISMS OF OCT2 AND MATE1 HAVE NO INFLUENCE ON PHARMACOKINETICS OF METFORMIN IN HEALTHY SUBJECTS.
    Kim, Y.
    Cho, S.
    Chung, J.
    Park, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S70 - S70
  • [2] Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters
    Gruen, Barbara
    Kiessling, Michael K.
    Burhenne, Juergen
    Riedel, Klaus-Dieter
    Weiss, Johanna
    Rauch, Geraldine
    Haefeli, Walter E.
    Czock, David
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (05) : 787 - 796
  • [3] The Effect of Genetic Variation in OCT1, OCT2 and MATE1 on Metformin Treatment Response
    Van Leeuwen, Nienke
    Nijpels, Giel
    Dekker, Jacqueline M.
    Welschen, Laura
    'T Hart, Leen M.
    DIABETES, 2011, 60 : A387 - A387
  • [4] In Vitro Inhibition of Renal OCT2 and MATE1 Secretion by Antiemetic Drugs
    George, Blessy
    Wen, Xia
    Jaimes, Edgar A.
    Joy, Melanie S.
    Aleksunes, Lauren M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [5] A gene-gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin
    Christensen, Mette M. H.
    Pedersen, Rasmus S.
    Stage, Tore B.
    Brasch-Andersen, Charlotte
    Nielsen, Flemming
    Damkier, Per
    Beck-Nielsen, Henning
    Brosen, Kim
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (10): : 526 - 534
  • [6] The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study
    Guchelaar, Niels A. D.
    Buck, Stefan A. J.
    van Doorn, Leni
    Hussaarts, Koen G. A. M.
    Sandberg, Yorick
    van der Padt-pruijsten, Annemieke
    van Alphen, Robbert J.
    Poppe-Manenschijn, Laura
    Vleut, Isolde
    de Bruijn, Peter
    van Leeuwen, Roelof W. F.
    Mostert, Bianca
    Eskens, Ferry A. L. M.
    Oomen-de Hoop, Esther
    Koolen, Stijn L. W.
    Mathijssen, Ron H. J.
    CLINICAL PHARMACOKINETICS, 2024, 63 (07) : 1037 - 1044
  • [7] OCT2 and MATE1 Provide Bidirectional Agmatine Transport
    Winter, Tate N.
    Elmquist, William F.
    Fairbanks, Carolyn A.
    MOLECULAR PHARMACEUTICS, 2011, 8 (01) : 133 - 142
  • [8] Effect of cimetidine, a model drug for inhibition of the organic cation transport (OCT2/MATE1) in the kidney, on the pharmacokinetics of glycopyrronium
    Dumitras, Swati
    Sechaud, Romain
    Drollmann, Anton
    Pal, Parasar
    Vaidyanathan, Sivakumar
    Camenisch, Gian
    Kaiser, Guenther
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (10) : 771 - 779
  • [9] Dual function of OCT2 and MATE1 in cisplatin induced nephrotoxicity
    El-Arabey, Amr Ahmed
    PHARMACOLOGICAL RESEARCH, 2017, 119 : 493 - 493
  • [10] FAMPRIDINE IS A SUBSTRATE AND INHIBITOR OF HUMAN OCT2, BUT NOT MATE1 AND MATE2K
    Rowbottom, Christopher
    Boiselle, Carri
    Gan, Lawrence
    Bohnert, Tonika
    Xiao, Guangqing
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S90 - S90
12345